Murphy, Middleton, Hinkle & Parker, Inc. Merck & Co., Inc. Transaction History

Murphy, Middleton, Hinkle & Parker, Inc.

$185 Million
Q3 2024

A detailed history of Murphy, Middleton, Hinkle & Parker, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Murphy, Middleton, Hinkle & Parker, Inc. holds 10,801 shares of MRK stock, worth $1.07 Million. This represents 0.66% of its overall portfolio holdings.

Number of Shares

10,801

Previous 11,140 3.04%

Holding current value

$1.07 Million

Previous $1.38 Million 11.09%

% of portfolio

0.66%

Previous 0.8%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$111.15 - $128.97 $37,679 - $43,720	-339 Reduced 3.04%	10,801 $1.23 Million
Q2 2024 Jul 16, 2024	SELL	$123.8 - $132.96 $17,579 - $18,880	-142 Reduced 1.26%	11,140 $1.38 Million
Q1 2024 Apr 11, 2024	SELL	$113.24 - $131.95 $113 - $131	-1 Reduced 0.01%	11,282 $1.49 Million
Q4 2023 Jan 24, 2024	SELL	$100.18 - $109.02 $25,946 - $28,236	-259 Reduced 2.24%	11,283 $1.23 Million
Q3 2023 Oct 03, 2023	SELL	$102.95 - $114.33 $4,323 - $4,801	-42 Reduced 0.36%	11,542 $1.19 Million
Q2 2023 Jul 05, 2023	SELL	$108.61 - $118.38 $4,344 - $4,735	-40 Reduced 0.34%	11,584 $1.34 Million
Q1 2023 Apr 05, 2023	SELL	$102.94 - $114.86 $18,940 - $21,134	-184 Reduced 1.56%	11,624 $1.24 Million
Q4 2022 Jan 17, 2023	BUY	$87.44 - $112.11 $786 - $1,008	9 Added 0.08%	11,808 $1.31 Million
Q3 2022 Oct 07, 2022	BUY	$84.53 - $94.96 $845 - $949	10 Added 0.08%	11,799 $1.02 Million
Q2 2022 Jul 29, 2022	SELL	$83.49 - $94.64 $3,339 - $3,785	-40 Reduced 0.34%	11,789 $1.08 Million
Q1 2022 Apr 14, 2022	SELL	$73.51 - $82.4 $2,866 - $3,213	-39 Reduced 0.33%	11,829 $971,000
Q4 2021 Jan 13, 2022	BUY	$72.28 - $90.54 $795 - $995	11 Added 0.09%	11,868 $910,000
Q3 2021 Oct 07, 2021	SELL	$71.68 - $78.83 $23,511 - $25,856	-328 Reduced 2.69%	11,857 $891,000
Q2 2021 Jul 13, 2021	SELL	$70.31 - $77.77 $2,038 - $2,255	-29 Reduced 0.24%	12,185 $948,000
Q1 2021 Apr 08, 2021	BUY	$68.86 - $81.11 $1,583 - $1,865	23 Added 0.19%	12,214 $942,000
Q4 2020 Jan 12, 2021	SELL	$71.77 - $79.65 $16,794 - $18,638	-234 Reduced 1.88%	12,191 $997,000
Q3 2020 Oct 13, 2020	SELL	$73.18 - $82.95 $32,784 - $37,161	-448 Reduced 3.48%	12,425 $1.03 Million
Q2 2020 Jul 08, 2020	BUY	$70.42 - $80.13 $985 - $1,121	14 Added 0.11%	12,873 $996,000
Q1 2020 Apr 09, 2020	SELL	$63.36 - $87.82 $62,789 - $87,029	-991 Reduced 7.16%	12,859 $989,000
Q4 2019 Jan 08, 2020	SELL	$77.58 - $87.54 $87,355 - $98,570	-1,126 Reduced 7.52%	13,850 $1.26 Million
Q1 2019 Apr 17, 2019	SELL	$69.58 - $79.36 $78,138 - $89,121	-1,123 Reduced 6.98%	14,976 $1.25 Million
Q2 2018 Jul 13, 2018	BUY	$50.83 - $59.72 $818,312 - $961,432	16,099 New	16,099 $977,000

Others Institutions Holding MRK

# of Institutions

3,820

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Murphy, Middleton, Hinkle & Parker, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Murphy, Middleton, Hinkle & Parker, Inc. with notifications on news.

Account

Murphy, Middleton, Hinkle & Parker, Inc. Merck & Co., Inc. Transaction History